|
2018-08-02 |
2018-07-31 |
B
Purchase
|
ROCHE HOLDINGS INC
Non-Executive Director
Large shareholder
|
2,343,078
+6.8%
137.00
USD 321,001,686
|
2,343,078
+6.8%
|
137.00
|
USD 321,001,686
|
|
|
2018-08-02 |
2018-07-31 |
B
Purchase
|
ROCHE HOLDINGS INC
Non-Executive Director
Large shareholder
|
13,877,949
+67.4%
137.00
USD 1,901,279,013
|
13,877,949
+67.4%
|
137.00
|
USD 1,901,279,013
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Nallicheri Melanie
Chief Business Officer
Officer
|
2,008
-3.0%
136.66
USD 274,413
|
2,008
-3.0%
|
136.66
|
USD 274,413
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Ryan Jason
Chief Financial Officer
Officer
|
3,403
-6.5%
136.66
USD 465,054
|
3,403
-6.5%
|
136.66
|
USD 465,054
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Hesslein Robert W.
SVP and General Counsel
Officer
|
2,520
-2.3%
136.66
USD 344,383
|
2,520
-2.3%
|
136.66
|
USD 344,383
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Fiedler Konstantin
Chief Operating Officer
Officer
|
994
-3.6%
136.66
USD 135,840
|
994
-3.6%
|
136.66
|
USD 135,840
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Cox Troy
Chief Executive Officer
Executive Director
|
1,402
-0.6%
136.66
USD 191,597
|
1,402
-0.6%
|
136.66
|
USD 191,597
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Miller Vincent A.
Chief Medical Officer
Officer
|
2,909
-4.2%
136.66
USD 397,544
|
2,909
-4.2%
|
136.66
|
USD 397,544
|
|
|
2018-07-05 |
2018-07-02 |
S
Sale
|
Doherty Michael J
Head of Product Development
Officer
|
2,675
-3.2%
136.66
USD 365,566
|
2,675
-3.2%
|
136.66
|
USD 365,566
|
|
|
2018-06-19 |
2018-06-15 |
PS
Planned sale
|
Pellini Michael J
Non-Executive Director
|
3,500
-3.3%
105.45
USD 369,075
|
3,500
-3.3%
|
105.45
|
USD 369,075
|
|
|
2018-05-23 |
2018-05-21 |
PS
Planned sale
|
Miller Vincent A.
Chief Medical Officer
Officer
|
1,570
-2.2%
85.00
USD 133,450
|
1,570
-2.2%
|
85.00
|
USD 133,450
|
|
|
2018-05-17 |
2018-05-16 |
PS
Planned sale
|
Cox Troy
Chief Executive Officer
Executive Director
|
2,157
-0.9%
77.10
USD 166,305
|
2,157
-0.9%
|
77.10
|
USD 166,305
|
|
|
2018-05-17 |
2018-05-15 |
PS
Planned sale
|
Pellini Michael J
Non-Executive Director
|
3,500
-3.2%
76.05
USD 266,175
|
3,500
-3.2%
|
76.05
|
USD 266,175
|
|
|
2018-05-09 |
2018-05-07 |
S
Sale
|
Cox Troy
Chief Executive Officer
Executive Director
|
7,063
-2.8%
70.01
USD 494,481
|
7,063
-2.8%
|
70.01
|
USD 494,481
|
|
|
2018-04-18 |
2018-04-16 |
PS
Planned sale
|
Ryan Jason
Chief Financial Officer
Officer
|
3,449
-6.2%
74.30
USD 256,261
|
3,449
-6.2%
|
74.30
|
USD 256,261
|
|
|
2018-04-18 |
2018-04-16 |
PS
Planned sale
|
Miller Vincent A.
Chief Medical Officer
Officer
|
3,283
-4.5%
74.02
USD 243,008
|
3,283
-4.5%
|
74.02
|
USD 243,008
|
|
|
2018-04-18 |
2018-04-16 |
PS
Planned sale
|
Pellini Michael J
Non-Executive Director
|
3,500
-3.1%
74.65
USD 261,275
|
3,500
-3.1%
|
74.65
|
USD 261,275
|
|
|
2018-04-05 |
2018-04-03 |
S
Sale
|
Doherty Michael J
Head of Product Development
Officer
|
2
-0.0%
72.40
USD 145
|
2
-0.0%
|
72.40
|
USD 145
|
|
|
2018-04-05 |
2018-04-03 |
S
Sale
|
Ryan Jason
Chief Financial Officer
Officer
|
1
-0.0%
72.40
USD 72
|
1
-0.0%
|
72.40
|
USD 72
|
|
|
2018-04-05 |
2018-04-03 |
PS
Planned sale
|
Pellini Michael J
Non-Executive Director
|
13,659
-10.7%
70.28
USD 959,955
|
13,659
-10.7%
|
70.28
|
USD 959,955
|
|
